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Several instances of Ir gene control of specific cytolytic T lymphocyte (CTL)  1 
responses have been reported. Simpson and Gordon (1) and von Boehmer et al. 
(2) described two complementing Ir genes that control the CTL response to the 
HY antigen and map in the I region of the H-2 complex. Schmitt-Verhulst and 
Shearer  (3)  observed that  spleen  cells  of mice bearing the  H-2 k haplotype 
develop CTL to trinitrophenyl (TNP)-conjugated syngeneic  cells that are specific 
only for modifications of the H-2K  but not H-2D region gene products. This 
response of H-2 k mice is under the dominant control of H-2-1inked Ir genes. In 
the preceding report  (4), we have investigated another genetic defect in the 
CTL primary response of H-2 k mouse spleen cells to TNP-conjugated cells in 
vitro. H-2 k spleen cells, in contrast to cells of other haplotypes, develop primary 
CTL  that  react solely with TNP-modified syngeneic cells and  do  not cross- 
reactively lyse  TNP-modified allogeneic spleen  target  cells.  The  ability  to 
produce cross-reactive CTL in response to TNP-conjugated H-2 k cells is domi- 
nant in spleen cells from (H-T  x  H-2b)F1 hybrid mice and does not reflect the 
inability of TNP-conjugated H-2 k cells to stimulate cross-reactive lysis by the 
appropriate responder-cell population. 
The relevant issue in systems that display major histocompatibility complex 
(MHC) control of CTL responsiveness is whether the restrictions observed are 
dictated by the H-2 genes of the responding T cell or by the H-2 gene products in 
the thymus where T cells differentiate and develop immunocompetence. Bevan 
(5) and Zinkernagel and associates (6, 7) have independently investigated this 
important question for CTL responses to cells bearing allogeneic minor histo- 
compatibility antigens or virally infected cells.  Such responses are normally 
restricted to produce CTL that preferentially lyse syngeneic  target cells bearing 
the appropriate antigens. By using semiallogeneic radiation chimeras or thy- 
mus grafts, these investigators have observed that the H-2-controlled genetic 
* Supported by National Institutes of Health grants CA-14723 and AI-13149. 
1  Abbreviations  used  in this paper:  B6, C57BL/6; CTL, cytolytic T lymphocytes; MHC, major 
histocompatibility  complex; MLC, mixed lymphocyte culture; TNP, trinitrophenyl. 
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restrictions that govern the specificity of CTL to virally infected syngeneic cells 
or to  cells bearing  minor  histocompatibility  antigens  are  not  dictated by the 
genome  of the  responding  cell but  rather  by the  environment  where  the  cell 
differentiated and, in the studies of Zinkernagel  et al. (6, 7), by the H-2 antigens 
of the thymus  graft. 
The  system  described  in  the  accompanying  paper  (4),  where  the  Ir  gene- 
controlled cross-reactive primary  CTL response to TNP-modified syngeneic cells 
was investigated, is well suited to study the role of the host H-2 antigens on the 
fine specificity of the T-cell clones that  develop during  differentiation.  Taking 
into account  that  primary  CTL  induced to TNP-modified  syngeneic cells from 
C3H  (H-2 k)  mice  are  unable  to  lyse  TNP-modified  allogeneic  targets,  bone 
marrow  cells from  "nonresponder"  C3H  mice were  allowed to differentiate  in 
lethally  iradiated  ~'responder"  (B6  ×  C3H)F1  (H-2  b~k) recipients.  The  ability 
of these  chimeric  C3H  cells  [C3H  -~  (B6  ×  C3H)F1]  to  display cross-reactive 
lysis  after  primary  stimulation  with  TNP-modified  C3H  cells was  assessed. 
The  C3H  (H-2  k)  CTL  which  differentiated  in  a  (B6  ×  C3H)F1  environment 
shared  similar levels of cross-reactive lysis as the  (B6  ×  C3H)F1  CTL,  demon- 
strating  the effect of the environment  where  T  cells differentiate on the speci- 
ficity of the primary  CTL response to TNP-modified  MHC  antigens. 
Materials  and  Methods 
Mice.  6- to 12-wk-old male mice were used in this study. C57BL/6 (B6), H-2b; BALB/c, H-2d; 
C3H/HeJ,  H-2k; DBAJl, H-2q; and (B6  x  C3H)F1,  H-2 blk hybrid mice were obtained from The 
Jackson Laboratory (Bar Harbor, Maine). 
Preparation of Chimeras.  The general method of Sprent et al. (8) was followed. Bone marrow 
cells were isolated from B6, C3H, and (B6 × C3H)F1 mice and washed several times. They were 
then treated twice with anti-Thy 1.2 antiserum and rabbit complement. 1.5  x  107 treated B6, 
C3H,  or (B6  x  C3H)FI bone marrow cells were then injected i.v. into lethally X-irradiated (675 
R)(B6  x  C3H)F~ hybrid mice. All irradiated mice receiving no bone marrow cells died within 1 
wk. F~ recipient animals were isolated 2 days before irradiation and maintained on antibiotics 
(Neosperin; Burroughs Wellcome Co., Research Triangle Park, N. C.) for 1 mo after irradiation. 
Survival was 80-90%  in all groups receiving bone marrow cells. Mice were histocompatibility 
typed and used for study 12-16 wk after irradiation. 
H-2 Typing.  Spleen cells from each radiation chimera were tissue typed by the microcytotox- 
icity assay (9) using anti-H-2 b [(B10.A x A)F~ anti-B10] and anti-H-2K  k [(B10 x LP.RIII)FI anti- 
2R] antisera plus complement. The percentage of F~ lymphocytes present in the spleen of all C3H 
(B6  x  C3H)FI radiation chimeras was  <2%  (which equals the lysis obtained with normal 
mouse serum in controls). 
Mixed Lymphocyte  Culture  (MLC).  5  ×  105  respender spleen cells were  cultured  in  fiat- 
bottomed microtiter wells  (Linbro Chemical Co.,  New  Haven,  Conn.)  in  the  presence of 10  e 
irradiated (1,500 R) splenic stimulator cells. Cells were cultured in RPMI 1640 medium supple- 
mental with 0.5% normal mouse serum,  2 mM glutamine,  100  U/ml of penicillin, 100  /~g/ml 
streptomycin, and 5 x  10 -5 M 2-mercaptoethanol. After 48 h cells were pulsed for 6 h with 0.25 ml 
of a  solution containing [3H]thymidine (40 mCi/ml). Acid-precipitable DNA was isolated and 
incorporated counts measured on a Beckman liquid scintillation counter (Beckman Instruments, 
Inc., Fullerton, Calif.). 
CTL Induction and the 5~Cr Release Assay.  Induction of CTL to allogeneic or TNP-medified 
syngeneic cells, the 51Cr release assay, and statistical methods are described in the preceding 
report  (4). In  some  experiments,  CTL  effectors  were  treated  with  anti-H-2  antiserum  and 
complement before incubation with 5~Cr-labeled target cells. They were incubated for 45 rain at 
room temperature with specific anti-H-2 antiserum, washed, and then incubated for 45 min at 
37°C with a 1:5 dilution of preselected rabbit complement. Cells were then washed several times 
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TABLE I 
Mixed Lymphocyte Responses of  Radiation Chimeras 
Net incorpora-  Stimulation 
Responder cells  Stimulator cells  tion*  index* 
cpm 
C3H  C3H  0  1.0 
C3H  B6  11,825  12.0 
C3H  BALB/c  14,932  15.0 
C3H-. (B6 × C3H)F  C3H  0  1.0 
C3H --* (B6 × C3H)F1  B6  -47  0.9 
C3H---, (B6 × C3H)F~  BALB/c  10,995  17.0 
* Represents incorporated counts per minute (cpm) in a typical  experiment. 
Counting error was usually <15%. Data represent triplicate  cultures with 
standard error <15% within groups. Control groups included: C3H anti- 
C3H:1,046 cpm, C3H --*  (B6 x C3H)FI anti-C3H:672 cpm, and (B6 × C3H)FI 
--* (B6 × C3H)FI anti-C3H:831  cpm. Net incorporated cpm was computed 
according to the equation: experimental group cpm minus syngeneically 
stimulated group cpm. 
* Computed according to the equation: experimental group cpm divided by 
control  group (stimulated with syngeneic cells)  cpm. 
of  antisera and complement that were used are listed  in Table IV. Conditions used for  antiserum 
plus complement lysis  yielded >95% lysis  of  appropriate targets  as  measured by dye exclusion. 
Results 
MLC Responses of  Normal and Chimeric Lymphoid Cells.  Table I shows an 
experiment in which the MLC responsiveness of normal and chimeric lymphoid 
cells is compared. It can be seen that chimeric C3H --* (B6  ×  C3H)FI lymphoid 
cells are unresponsive to either C3H or B6 stimulator cells but are stimulated 
by BALB/c cells bearing the unrelated H-2 d haplotype. 
Normal C3H  lymphoid cells responded to beth B6  and BALB/c stimulator 
cells. Thus, by the criteria of MLC responsiveness, chimeric C3H are tolerant to 
B6 antigens. 
CTL Responsiveness of Normal and Chimeric Spleen Cells.  Normal C3H 
spleen cells can be induced by allogeneic cells to lyse H-2 b or H-2 d tumor or 
normal spleen targets; however, chimeric C3H --* (B6  ×  C3H)F1 spleen cells do 
not lyse H-2 b targets while lysing H-2 d targets well (Table II). Though unable 
to respond to H-2 b stimulator cells, the chimeric C3H cells were able to respond 
to  TNP-modified B6  stimulator cells.  Chimeric C3H  cells  also  responded  to 
TNP-modified C3H cells. 
Cross-Reactive  Lysis  by CTL from Normal and Chimeric Mice.  We next 
asked whether the ability to lyse TNP-modified allogeneic targets after stimu- 
lation with TNP-modified syngeneic cells was  altered in the  C3H --*  (B6  × 
C3H)F1  chimeric  mice.  Results  shown  in  Table  III  demonstrate,  as  in  the 
preceding report (4), that normal C3H CTL induced by TNP-modified syngeneic 
cells only lyse TNP-ceupled syngeneic cells, i.e. they do not demonstrate cross- 
reactive lysis on TNP-coupled allogeneic cells. 
When C3H --*  (B6  ×  C3H)F~  spleen cells are stimulated by TNP-modified 
C3H spleen cells, CTL are produced that lyse TNP-ceupled syngeneic (C3H) and P.  BILLINGS,  S.  J.  BURAKOFF,  M.  E.  DORF,  AND  B.  BENACERRAF 
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Group  Respender cells  Stimulator cells Target cells*  Percent spe- 
cific  release* 
I  C3H  B6  B6  32 
C3H  BALB/c  BALB/c  24 
C3H  B6  B6  5 
C3H  BALB/c  BALB/c  25 
II 
III 
--* (B6 x C3H)F, 
--* (B6 x C3H)F1 
C3H  B6TNP  B6  32 
C3H--* (B6 x  C3H)FI  B6TNP  B6  1 
C3H--* (B6 x C3H)F1  B6TNP  B6TNP  30 
C3H  C3H TNP  C3H  0 
C3H  C3H TNP  C3H TNP  63 
C3H--* (B6 x C3H)FI  C3H TNP  C3H  0 
C3H --* (B6 x C3H)FI  C3H TNP  C3H TNP  53 
* Spontaneous release  from spleen targets  was <40%. 
Effector  to target ratios  used:  group I, 15:1;  group II, 30:1;  and group III,  80:1. 
TABLE III 
Cross-Reactive  Lysis by CTL from Radiation Chimeras 
Group  Respender cells 
TNP-modi- 
TNP-modified  Percent cross-  fled stimu- 
lator cells  target cells*  reactive lysis* 
II 
III 
B6 (H-T)  B6  B6  100 (50) 
B6  B6  BALB/c (H-2  d)  45 
C3H (H-T)  C3H  C3H  100 (50) 
C3H  C3H  BALB/c  10 
C3H--+ (B6 x C3H)F~  C3H  C3H  100 (50) 
C3H--+ (B6 × C3H)F1  C3H  BALB/c  40 
C3H  C3H  C3H  100 (50) 
C3H  C3H  DBA/1 (H-2q)  4 
C3H--* (B6 x C3H)F1  C3H  C3H  100 (50) 
C3H--* (B6 x C3H)FI  C3H  DBA/1  30 
C3H  C3H  C3H  100 (50) 
C3H  C3H  B6 (H-T)  2 
C3H--* (B6 x C3H)FI  C3H  C3H  100 (50) 
C3H--* (B6 x C3H)FI  C3H  B6  50 
* Spontaneous release of normal spleen targets was <40%. 
* In group I, effector to target ratios of 40:l for B6 and C3H, and 80:1 for C3H --* (B6 
×  C3H)F1 CTL were used. In groups H and III effector to target ratios of 48:1 for 
C3H  and  40:1 for  C3H  ~  (B6  x  C3H)F1 were  used.  Numbers  in  parentheses 
represent percent specific release on syngeneic TNP-modified target cells. 
TNP-coupled allogeneic (BALB/c, B6, DBAJ1) targets. Therefore, the specificity 
of CTL induced by TNP-modified syngeneic antigens is altered when C3H cells 
differentiate in a  (B6  ×  C3H)F1 environment. 
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TABLE IV 
Characterization of CTL from Radiation Chimeras by Anti-H-2 Serum 
Experi- 
ment 
TNP-modi-  TNP-modified tar-  Responder cells  fled stimu- 
lator cells  get cells* 
Antiserum plus comple- 
ment treatment of CTL$ 
Anti-  Anti-  Control  H.2  b  H.2  k 
% 
B6 (H-2  b)  B6  B6  30  3  - 
B6  B6  BALB/c (H-2  d)  20  0  - 
C3H (H-2  k)  C3H  C3H  42  -  - 
C3H  C3H  BALB/c  1  -  - 
C3H-* (B6 × C3H)F,  C3H  C3H  48  48  - 
C3H ~  (B6 × C3H)F,  C3H  BALB/c  11  14  - 
B6  B6  B6  36  0  33 
C3H  C3H  C3H  56  -  - 
C3H  C3H  DBA/1 (H-2)  1  -  - 
C3H-* (B6 × C3H)F1  C3H  C3H  33  30  0 
C3H--* (B6 × C3H)F,  C3H  DBA/1  18  21  0 
* Spontaneous release of normal spleen targets was <40%. 
$ Data is percent specific release. Effector to target ratio in experiment 1 was 40:1 and experiment 
2, 50:1. Control represents percent specific release of untreated effector cells. Anti-H-2  b serum: 
(A x  B10.A)F1 anti-B10 and anti-H-T serum: (B10 ×  LP.RIII)F1 anti-B10.A(2R) were used at 
dilutions of 1:2 to lyse effector cells. 
small  number  of residual  (B6  ×  C3H)F1  CTL  could explain  the  cross-reactive 
lysis produced  in  C3H  --~  (B6  ×  C3H)F1  chimeric  mice.  Results  in  Table  IV 
demonstrate  that anti-H-2 b antiserum  plus complement  treatment,  although  it 
removes  100%  of the  B6  CTL which  lyse TNP-coupled  allogeneic targets  after 
TNP-modified B6 spleen-cell stimulation,  does not affect the cross-reactive lysis 
produced  by  C3H  --*  (B6  ×  C3H)F1  CTL  induced  by  TNP-modified  C3H 
stimulators.  Anti-H-T  antiserum  plus complement  treatment  completely elim- 
inates functional cross-reactive CTL from the chimeric CTL population.  When 
these data are considered along with the H-2 typing data, showing that  >98% of 
all spleen cells from C3H -~ (B6  ×  C3H)F1 mice bear H-2 k antigens before CTL 
induction,  it  is  clear  that  the  cross-reactive  lysis seen  when  C3H  --*  (B6  × 
C3H)FI  spleen  cells are  induced  by TNP-modified  C3H  stimulators  is due  to 
CTL of C3H origin, and not to contaminating  F1 cells. 
Discussion 
Bone marrow cells  from H-2  k  C3H mice have been allowed to mature in an 
irradiated (H-2  b~k)  (B6 × C3H)FI recipient.  Spleen cells  from these chimeric 
mice, which were of  C3H origin,  were found to  be  tolerant  to B6 alloantigen  in 
beth the mixed lymphocyte reaction  and by cell-mediated  cytotoxicity.  These 
chimeric spleen  cells  when stimulated in vitro  with TNP-modified syngeneic 
cells  now demonstrated cross-reactive  lysis  of  TNP-modified allogeneic  targets 
(i.e.  TNP-BALB/c, TNP-DBA/1, and  TNP-B6 targets).  The  effector  cells  exhibit- 
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plus complement and were unaffected by anti-H-2 b antiserum plus complement 
treatment; thus eliminating any role for contaminating FI effector cells. 
The  data  therefore demonstrate that  the  pattern  of CTL  responsiveness 
generated by primary immunization with TNP-modified syngeneic cells can be 
altered  by  the  environment  in  which  the  T  cell  differentiated.  In  these 
experiments, C3H T cells, which normally are unable to exhibit cross-reactive 
lysis after primary in vitro immunization with TNP-modified syngeneic cells, 
exhibit the cross-reactive phenotype if they differentiated in a  host that does 
exhibit cross-reactive lysis. 
These findings are in agreement with recent observations of Zinkernagel et 
al.  (6,  7)  and Bevan  (5). Zinkernagel et al.  demonstrated that T  cells from 
radiation chimeras develop virus-specific CTL only when presented with virally 
infected cells that carry the H-2  antigens of the irradiated recipients. From 
studies with thymus grafts, Zinkernagel et al. (6, 7) were able to conclude that 
the radioresistant portion of the thymus bears the H-2 antigens involved in 
restricting virus-specific killer T-cell precursors. Though the influence of the 
chimeric host on the specificity of CTL to TNP-modified syngeneic antigens is 
quite apparent from our studies, we cannot conclude that this effect is due to 
the host thymus without further studies involving thymic transplants. 
Inasmuch as  macrophages have been demonstrated to be  involved in  the 
induction  of immune responses  in  many systems  (10), the  possibility  that 
residual (B6  ×  C3H)F1 macrophages are responsible for our results must be 
entertained. It is unlikely, however, that this is the case. Zinkernagel et al. (7) 
demonstrated that, in long-term irradiation bone marrow chimeras, the lym- 
phoreticular system had been replaced by cells derived from the reconstituting 
stem cells. In fact, Zinkernagel was required to adoptively transfer chimeric 
spleen cells into a recently irradiated recipient and then virally infect in order 
to  utilize  the  host  lymphoreticular system  for  viral  antigen  presentation. 
Because we waited 3-4 mo before testing our radiation chimeras, it is unlikely 
that FI macrophages continued to populate the spleen. 
Our results could also be explained by loss of a regulatory cell that normally 
restricts the response to C3H CTL, i.e. suppressing cross-reactive lysis. It could 
be argued that C3H bone marrow cells developing in a  (B6  × C3H)F~ environ- 
ment lose these clones of regulatory cells. However, attempts at demonstrating 
such a regulatory cell so far have been unsuccessful; specifically, treatment of 
C3H  mice with cyclophosphamide or  adult  thymectomy does not  appear  to 
reverse the H-2 restriction (data not shown). 
It is still not clear how the host environment, presumably the H-2 antigens of 
the thymus, influences T-cell maturation to produce the phenotypic response 
pattern characteristic of the adult animal. Jerne (11) originally proposed that 
the earliest antigen receptors expressed on lymphocytes are specific for self-H-2 
antigens. Precursors of CTL presumably express receptors for self-H-2K and H- 
2D,  and  proliferate in  the  thymic environment in  response  to  these  MHC 
products. During this proliferation, the receptors of these CTL precursors are 
postulated to undergo either selectional and]or mutational changes, ultimately 
yielding the fully mature receptor pool with preferential specificity for slight 
variants  of the  original  self-MHC  products  as  discussed previously (12-16). 
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basis for the hierarchy of  allogeneic, xenogeneic, and modified self-responses, as 
well as the responses of chimeric mice to modified self-antigens. Furthermore, 
this model may have important implications for humoral or DTH-type responses 
for which responder status is regulated by I  region genes.  It is still an open 
issue whether some types of Ir gene control are expressed directly in the T cell 
or indirectly by I region genes in the thymus, affecting the differentiation of T- 
cell precursors  in a  manner similar to  H-2K  and H-2D  for CTL.  This latter 
mechanism may in  some  cases  be  interpreted  as  Ir  gene  expression  in  the 
macrophages or B cells with which the T cell must interact via antigen and Ia. 
However, we favor the alternative that in many instances Ia antigens them- 
selves on macrophages and/or B cells control T-cell antigen recognition inde- 
pendently of receptor repertoire regulation in the thymus. These issues, which 
pertain to both K-, D-,  and I-restricted responses, remain to be resolved by a 
combination of the current approach using chimeras and careful cell separation 
and mixing experiments to define the cell(s) involved in the altered response 
pattern  of lymphocytes whose  precursors  have  differentiated in  a  "nonself" 
environment. 
Summary 
Bone marrow cells from C3H (H-2 k) mice, a strain that does not exhibit cross- 
reactive lysis of trinitrophenyl (TNP)-modified allogeneic targets, were allowed 
to mature in heavily irradiated (B6  ×  C3H)FI (H-2 b/k) recipients, an F1 hybrid 
that  does  demonstrate cross-reactive lysis.  Spleen  cells from these  chimeric 
mice were removed after 3-4 mo and by H-2 typing shown to be of C3H origin. 
These cells were found to be tolerant to B6 alloantigens by mixed lymphocyte 
reaction  and  cell-mediated cytotoxicity and,  when  stimulated in  vitro  with 
TNP-modifled syngeneic cells, now cross-reactively lysed TNP-modified alloge- 
neic targets.  These studies demonstrate that the host environment where T 
cells differentiate influences the specificity of the primary cytolytic T-lympho- 
cyte (CTL) response to TNP-modified syngeneic antigens. 
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